DIARYL ETHERS AS OPIOID RECEPTOR ANTAGONIST

A compound of the formula (I) wherein the variables X1 to X10, R to R including R<3'>, E, v, y, z, A and B are as described, or a pharmaceutically acceptable salt, solvate, enantiomer, racemate, diastereomer or mixtures thereof, useful for the treatment, prevention or amelioration of obes...

Full description

Saved in:
Bibliographic Details
Main Authors STUCKY, RUSSELL, DEAN, CHAPPELL, MARK, DONALD, SIEGEL, MILES, GOODMAN, SMITH, DANA, RAE, WOLFE, CHAD, NOLAN, FRITZ, JAMES, ERWIN, PEDREGAL-TERCERO, CONCEPCION, DIAZ BUEZO, NURIA, TAKEUCHI, KUMIKO, HOLLOWAY, WILLIAM, GLEN, QUIMBY, STEVEN, JAMES, BLANCO-PILLADO, MARIA-JESUS, DE LA TORRE, MARTA, GARCIA, THOMAS, ELIZABETH, MARIE, MATT, JAMES, EDWARD, JUNIOR, MITCH, CHARLES, HOWARD
Format Patent
LanguageEnglish
French
Published 01.04.2004
Edition7
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A compound of the formula (I) wherein the variables X1 to X10, R to R including R<3'>, E, v, y, z, A and B are as described, or a pharmaceutically acceptable salt, solvate, enantiomer, racemate, diastereomer or mixtures thereof, useful for the treatment, prevention or amelioration of obesity and Related Diseases is disclosed. L'invention concerne un composé de formule (I), dans laquelle les variables X1 à X10, R à R comprennent R<3'>, E, v, y, z, A et B sont tels que définis dans la description ou représentent un sel pharmaceutiquement acceptable, un solvate, un énantiomère, un racémate, un diastéréomère ou un de leurs mélanges. Ledit composé est utilisé dans le traitement, la prévention ou l'amélioration de l'obésité et des maladies associées.
Bibliography:Application Number: WO2003US26300